Patients and Medical
From complexity to clarity in cell and gene therapy
Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities
More Clinical Articles
Access and Evidence
Survey results: Accelerating digital transformation during COVID-19
View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations
Clinical
Breaking new ground in healthcare data
Pharma should team up with HCPs, regulators and health ministries to create harmonised, interoperable health records and so drive cheaper, faster insights
Patients and Medical
Building a bridge to a COVID-19 vaccine
Regeneron shares its latest progress on therapies for the pandemic at eyeforpharma Philadelphia virtual
Clinical
Moving remote: the post-pandemic clinical trial
Pharma is rapidly adapting its approach to trials in the face of the pandemic and there is great opportunity for far reaching improvements once this is all over
Clinical
Imagining the ‘Digitome’
Dramatic advances in human health beckon if pharma can help build ‘the Digitome’, a vast data commons
Clinical
RWE: A new hope for rare disease
RWE shows great promise in helping accelerate treatments for rare disease
Access and Evidence
Into pharma's roaring twenties
A new decade is here. And despite the incredible science, pharma is ill-equipped.
Clinical
Telemedicine: The future of clinical trials?
There is a new surge of interest in telemedicine’s potential to optimize clinical trials, but is this what patients want?
Clinical
Clinical must think outside, and inside the box
From site-in-a-box to virtual/siteless trials: which new model will successfully disrupt clinical research?